Literature DB >> 6883828

Continuous electrocardiographic monitoring in patients with sickle-cell anemia during pain crisis.

A Maisel, H Friedman, L Flint, M Koshy, R Prabhu.   

Abstract

Electrocardiographic studies in patients with sickle-cell anemia have been performed during the normal resting state with routine twelve-lead ECGs. We studied 30 patients with sickle-cell disease in acute crisis with 24-hour continuous electrocardiographic monitoring. The standard ECG demonstrated a high incidence of abnormalities, but only three patients had arrhythmias. These findings contrasted sharply with the results of continuous monitoring, during which arrhythmias were detected in 24 of 30 patients. They were fairly evenly split between atrial (60%) and ventricular (67%). Nine of the patients had "complex arrhythmias" including two with episodes of ventricular tachycardia. Seventeen patients subsequently underwent equilibrium gated-blood pool scans. Eight patients had abnormal contractility and tended to have more arrhythmias on monitoring than those with normal contractility. Thus, continuous electrocardiographic monitoring of sickle-cell patients during crisis revealed a higher incidence of arrhythmias than previously thought.

Entities:  

Mesh:

Year:  1983        PMID: 6883828     DOI: 10.1002/clc.4960060707

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  9 in total

Review 1.  Cardiovascular abnormalities in sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev
Journal:  J Am Coll Cardiol       Date:  2012-03-27       Impact factor: 24.094

2.  Cardiovascular autonomic dysfunction in sickle cell anemia: a possible risk factor for sudden death?

Authors:  J C Romero Mestre; A Hernández; O Agramonte; P Hernández
Journal:  Clin Auton Res       Date:  1997-06       Impact factor: 4.435

3.  Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease.

Authors:  Courtney D Fitzhugh; Naudia Lauder; Jude C Jonassaint; Marilyn J Telen; Xiongce Zhao; Elizabeth C Wright; Francis R Gilliam; Laura M De Castro
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

4.  Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease.

Authors:  Hui Wang; Wei Luo; Jintao Wang; Chiao Guo; Stephanie L Wolffe; Julia Wang; Eddy B Sun; Kori N Bradley; Andrew D Campbell; Daniel T Eitzman
Journal:  Br J Haematol       Date:  2013-04-17       Impact factor: 6.998

Review 5.  Myocardial infarction in sickle cell disease: use of translational imaging to diagnose an under-recognized problem.

Authors:  Paul Chacko; Eric H Kraut; Jay Zweier; Charles Hitchcock; Subha V Raman
Journal:  J Cardiovasc Transl Res       Date:  2012-11-21       Impact factor: 4.132

6.  IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias.

Authors:  Akash Gupta; Yu-Dong Fei; Tae Yun Kim; An Xie; Ken Batai; Ian Greener; Haiyang Tang; Sultan Ciftci-Yilmaz; Elizabeth Juneman; Julia H Indik; Guanbin Shi; Jared Christensen; Geetanjali Gupta; Cheryl Hillery; Mayank M Kansal; Devang S Parikh; Tong Zhou; Jason X-J Yuan; Yogendra Kanthi; Peter Bronk; Gideon Koren; Rick Kittles; Julio D Duarte; Joe G N Garcia; Roberto F Machado; Samuel C Dudley; Bum-Rak Choi; Ankit A Desai
Journal:  Blood       Date:  2021-03-04       Impact factor: 25.476

Review 7.  Iron overload and arrhythmias: Influence of confounding factors.

Authors:  Yukitaka Shizukuda; Douglas R Rosing
Journal:  J Arrhythm       Date:  2019-06-20

8.  Sickle cell disease-associated arrhythmias and in-hospital outcomes: Insights from the National Inpatient Sample.

Authors:  Upenkumar Patel; Rupak Desai; Bishoy Hanna; Dhruval Patel; Shahzad Akbar; Mohammed Zubair; Gautam Kumar; Rajesh Sachdeva
Journal:  J Arrhythm       Date:  2020-08-08

9.  Troponin Elevation in Sickle Cell Disease.

Authors:  Nuri I Akkus; Saurabh Rajpal; Jeffrey Hilbun; Ashish Dwary; Thomas R Smith; George Mina; Pratap C Reddy
Journal:  Med Princ Pract       Date:  2021-06-02       Impact factor: 1.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.